Morse Asset Management’s Emergent Biosolutions EBS Stock Holding History

Morse Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54M	Sell	183,334 -38,465	-17%	-$322K	0.25%	76
2026 Q1	$1.84M	Sell	221,799 -7,509	-3%	-$77.8K	0.38%	63
2025 Q4	$2.83M	Buy	229,308 +11,383	+5%	+$122K	0.57%	52
2025 Q3	$1.92M	Buy	217,925 +9,881	+5%	+$76.9K	0.38%	65
2025 Q2	$1.33M	Buy	208,044 +20,580	+11%	+$118K	0.29%	77
2025 Q1	$911K	Buy	187,464 +28,645	+18%	+$237K	0.23%	83
2024 Q4	$1.52M	Buy	+158,819	New	+$1.46M	0.35%	66
2024 Q3	–	Sell	-14,200	Closed	-$97K	–	345
2024 Q2	$97K	Buy	+14,200	New	+$61.1K	0.02%	142
2019 Q1	–	Sell	-27,050	Closed	-$1.6M	–	130
2018 Q4	$1.6M	Buy	27,050 +2,950	+12%	+$190K	0.57%	48
2018 Q3	$1.59M	Hold	24,100	–	–	0.42%	69
2018 Q2	$1.22M	Buy	24,100 +11,180	+87%	+$582K	0.33%	75
2018 Q1	$680K	Buy	+12,920	New	+$644K	0.19%	96

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Morse Asset Management's EBS Position: Q2 2026 in Review

Morse Asset Management reduced its Emergent Biosolutions (EBS) stake by 17% in Q2 2026, selling an estimated $322K and leaving 183,334 shares worth $1.54M. The position accounts for 0.25% of the portfolio, ranked #76.

Morse Asset Management first reported a position in EBS in Q1 2018 and has held it in 12 quarters since. The position peaked at $2.83M in Q4 2025. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Morse Asset Management held 183,334 shares of Emergent Biosolutions worth $1.54M as of Q2 2026.
Morse Asset Management sold 38,465 Emergent Biosolutions shares in Q2 2026, an estimated $322K.
Emergent Biosolutions made up 0.25% of Morse Asset Management's portfolio in Q2 2026, its #76 holding.
Morse Asset Management first reported a position in Emergent Biosolutions in Q1 2018 and has held it in 12 quarters since.
Morse Asset Management's Emergent Biosolutions position peaked at $2.83M in Q4 2025.
194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.